| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 |
| filingDate |
1989-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88c82ab6e629957c2996740a11e9305f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4043a4adcbbe9906328952c999fb6719 |
| publicationDate |
2000-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
SK-281011-B6 |
| titleOfInvention |
ORAL FORM OF THE MEDICINAL PRODUCT |
| abstract |
An oral drug form in which the matrix and the fraction of foam or cavities together form the body of the drug, wherein the fraction of foam or cavities is continuous or divided within the body or forms a sub-body adjacent to the membrane. The system is maintained in this condition under the conditions in the stomach for a sufficiently long period of time to release the active ingredient. |
| priorityDate |
1988-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |